|
OPA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.379690E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.215900E-03 |
| Normal-vs-Stage2 |
9.343800E-01 |
| Normal-vs-Stage3 |
5.831500E-04 |
| Normal-vs-Stage4 |
1.06359999996197E-06 |
| Stage1-vs-Stage2 |
9.222600E-03 |
| Stage1-vs-Stage3 |
2.497600E-01 |
| Stage1-vs-Stage4 |
6.436900E-03 |
| Stage2-vs-Stage3 |
1.683130E-03 |
| Stage2-vs-Stage4 |
1.69801999999608E-05 |
| Stage3-vs-Stage4 |
8.505600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.256740E-03 |
| Normal-vs-AfricanAmerican |
1.045160E-01 |
| Normal-vs-Asian |
4.616300E-03 |
| Caucasian-vs-AfricanAmerican |
4.859800E-01 |
| Caucasian-vs-Asian |
8.320000E-01 |
| AfricanAmerican-vs-Asian |
4.063600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.42140000000069E-05 |
| Normal-vs-Female |
6.984100E-03 |
| Male-vs-Female |
9.656000E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.803400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.555410E-03 |
| Normal-vs-Age(61-80Yrs) |
5.661900E-03 |
| Normal-vs-Age(81-100Yrs) |
6.596400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.054200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.896200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.727000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.729000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.499600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.729600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.232700E-04 |
| Classical-VS-Follicular |
1.687830E-01 |
| Classical-VS-Other |
4.305500E-02 |
| Classical-VS-Normal |
2.497300E-03 |
| Tall-VS-Follicular |
2.577700E-04 |
| Tall-VS-Other |
4.501200E-01 |
| Tall-VS-Normal |
2.11090000001857E-06 |
| Follicular-VS-Other |
4.054100E-02 |
| Follicular-VS-Normal |
1.640440E-01 |
| Other-VS-Normal |
1.296900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.189870E-02 |
| Normal-vs-N1 |
2.04349999999298E-05 |
| N0-vs-N1 |
2.020000E-03 |
|
|
